Submission ID Name Format Sort Descending Submitter Submitted Modified Certification
DDMODEL00000127 Bueno_PreclinicalBiomarkerTGI PharmML Niklas Hartung 2015/12/14 2016/07/15 uncertified model
DDMODEL00000002 Friberg_2009_Schizophrenia_Asenapine_PANSS PharmML Zinnia Parra-Guillen 2014/09/24 2016/05/18 uncertified model
DDMODEL00000213 Li_2006_PK_Meropenem_AdultPatients PharmML Lisa Ehmann 2016/08/26 2016/08/30 uncertified model
DDMODEL00000094 Insulin sensitivity from labeled IVGTT PharmML Roberto Bizzotto 2015/12/10 2016/05/18 uncertified model
DDMODEL00000195 Sibrotuzumab_PK_Carcinoma PharmML Niklas Hartung 2016/05/31 2016/07/15 uncertified model
DDMODEL00000229 A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML) PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
DDMODEL00000132 Minimal model PharmML Roberto Bizzotto 2015/12/29 2016/05/18 uncertified model
DDMODEL00000103 Trefz_2015_metabolism_Kuvan_TurnoverKPD PharmML Nadia Terranova 2015/12/11 2016/07/18 uncertified model
DDMODEL00000090 Claret_2009_oncology_capecitabine_TGI PharmML Nadia Terranova 2015/12/10 2016/07/13 uncertified model
DDMODEL00000128 Ribba_2012_PCV PharmML Christian Laveille 2015/12/15 2015/12/16 uncertified model
Showing 111 to 120 of 151 models